Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-028360
Filing Date
2025-02-27
Accepted
2025-02-27 07:25:42
Documents
17
Effectiveness Date
2025-02-27

Document Format Files

Seq Description Document Type Size
1 S-8 dyn-20250226.htm S-8 117313
2 EX-5.1 dyn-ex5_1.htm EX-5.1 20026
3 EX-23.1 dyn-ex23_1.htm EX-23.1 4940
4 EX-FILING FEES dyn_exfilingfees.htm   iXBRL EX-FILING FEES 36639
5 GRAPHIC img40885939_0.jpg GRAPHIC 19273
6 GRAPHIC img40885939_1.jpg GRAPHIC 299556
  Complete submission text file 0000950170-25-028360.txt   751931

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT dyn_exfilingfees_htm.xml XML 6752
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

EIN.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285305 | Film No.: 25673008
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)